Picture of Alk-Abello A/S logo

ALK B — Alk-Abello A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: ALK-Abello Says Itulatek Approved For Treatment Of Children And Adolescents In Canada

May 8 (Reuters) - ALK-Abello A/S ALKb.CO:

REG-ITULATEK® APPROVED FOR TREATMENT OF CHILDREN AND ADOLESCENTS IN CANADA

PAEDIATRIC REGULATORY REVIEWS IN SWITZERLAND, UK ARE EXPECTED TO COMPLETE IN 2025

Source text: ID:nGNE3LQPZp

Further company coverage: [ALKb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Alk-Abello A/S

See all news